Companies · Other Health Care

GHR Acquisition, LLC

HOUSTON · Other Health Care

Diligence memoA one-page analyst read on GHR Acquisition, LLC — recommendation, valuation, rhythm, risks.
$35.3M
Total raised · real
3
Rounds
0.5×
Latest step-up
Top 11%
Sector rank · raised
Series B
Latest stage · inferred · Fri Jul 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

GHR Acquisition, LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.33× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

GHR Acquisition, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
9.4 yr record
Peak capital year was 2017 with $29.7M across 2 filings.
Market position
ahead of 90% of Other Health Care peers
Capital scale is ahead of 90% of Other Health Care peers; modeled value is above 83% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2017: $29.7M across 2 filings.
  • Largest single filing was $19.4M on 2017-02-15.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

GHR Acquisition, LLC is one of 5376 Other Health Care companies tracked from HOUSTON. By capital raised it ranks among the largest (ahead of 90% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
24
Investors (latest)
2017
Year incorporated
2019-07-26
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2017-02-15 Raised $19M (real) Modeled valuation $430M (est)$19M$430MSeries B2017Series B · 2017-03-31 Raised $10M (real) Modeled valuation $227M (est)$10M$227MSeries B2017Series B · 2019-07-26 Raised $5.6M (real) Modeled valuation $124M (est)$5.6M$124MSeries B2019+$10M+$5.6MCumulative $35M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$19.4M · 2017
Series B extension$10.3M · 2017
Series B extension$5.6M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$123.9M
Base estimate est.
$13.1M
Conservative case
$476.8M
Upside case
$31.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $429.8M · 2017-02-152017Series B · modeled $227.4M · 2017-03-31Series B · modeled $123.9M · 2019-07-262019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
6.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
15 mo
Avg between rounds
$14.5M/yr
Capital velocity
9.4 yr
On record since
2017
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 15× above median
This company$35.3M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.3× of median
This company$5.6M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 5.6× above median
This company$123.9M
Sector median$22.1M

Raised more than 90% of sector peers (real $). Modeled value above 83% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #64 of 78.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $756.4M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)National Spine & Pain Centers Holdings, LLC · Series B Raised $32.0M · modeled $708.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $620.8M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)GHR Acquisition, LLC (this company) Raised $35.3M · modeled $123.9M (est)GHR Acquisition, LLC
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.37×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$756.4M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLCSeries B$32.0M$708.9M1.90×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.87×
Lotus Parent, Inc.Series B$31.2M$690.4M1.85×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$620.8M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
GHR Acquisition, LLC this companySeries B$35.3M$123.9M0.33×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$19.4M2017-02-15$107.8M$429.8M90%
Series B$10.3M2017-03-31$57.0M$227.4M90%
Series B$5.6M2019-07-26$31.1M$123.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$19.4M2017-02-15
    • First recorded raise — entered as Series B.
    • 18 investors on this round.
  2. Series B$10.3M2017-03-31
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 23 investors on this round.
  3. Series B$5.6M2019-07-26
    • Raised again after 28 mo — slower than the ~14 mo sector norm.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 24 investors on this round.
Intelligence
2020 ~Q4
Modeled next raise · ~15mo cadence
$5.6M
Modeled next size est.range $5.6M$8.9M
0.5×
Last step-up
$14.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Joseph Kaplan5 other2017-02
Fred Brown4 other2017-02
Joseph O'Neill2 other2017-02
Livingston Kosberg2 other2017-02
Mark Brookner2 other2017-02
Janet Elkin1 other2017-03
Bradley Morgan2017-02
Cheryl Wilhelm2017-03
Gordon Michael Dunagan2017-03
Jeffrey Crater2019-07
Laura Magner2017-03
Scott Nichols2017-02
Vik Kalra2019-07
Registry & provenance

GHR Acquisition, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1698627
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Hydro Ex Acquisition, LLCOther EnergySeries A$14.6M$154.0Mnetwork4 shared operators
Newco Environmental, LLCOther EnergySeed$3.6M$46.7Mnetwork4 shared operators
Nextcare Holdings IncOther Health CareSeries B$57.2M$221.5Mnetwork1 shared operator · same sector · same stage
HomeThrive, Inc.Other Health CareSeries B$35.3M$131.8Msame sector · same stage
STX Healthcare Management Services, Inc.Other Health CareSeries B$35.7M$128.2Msame sector · same stage
General Fluidics CorpOther Health CareSeries B$34.6M$119.3Msame sector · same stage
Optimal IMX, Inc.Other Health CareSeries B$34.6M$99.7Msame sector · same stage
Myra Vision, Inc.Other Health CareSeries B$36.0M$108.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
GLW, Inc.Other Health CareSeries A$48.5M87%
Arthron Investments, LLCOther Health CarePre-Seed$1.2M87%
Dhh LlcOther Health CarePre-Seed$2.2M84%
Glbesc, LlcOther Health CareSeed$23.5M84%
Gvm2023, LlcOther Health CarePre-Seed$2.7M84%
Pan-Am Acquisition, LLCOther Health CareSeed$9.3M84%
Gynion, LLCOther Health CarePre-Seed$12.0M83%
Arthrofree LLCOther Health CarePre-Seed$5.9M83%
Frequently asked
How much funding has GHR Acquisition, LLC raised?
GHR Acquisition, LLC has raised approximately $35.3M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is GHR Acquisition, LLC's estimated valuation?
Provath's modeled valuation for GHR Acquisition, LLC is approximately $123.9M (modeled range $13.1M–$476.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is GHR Acquisition, LLC at?
GHR Acquisition, LLC's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Jul 26.
What does GHR Acquisition, LLC do and where is it based?
GHR Acquisition, LLC operates in the Other Health Care sector, based in HOUSTON.
Explore related

See where GHR Acquisition, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at GHR Acquisition, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.